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ABSTRACT Lgl family members play an important role in the regulation of cell polarity in 
eukaryotic cells. The yeast homologues Sro7 and Sro77 are thought to act downstream of the 
Rab GTPase Sec4 to promote soluble N-ethylmaleimide–sensitive factor adaptor protein re-
ceptor (SNARE) function in post-Golgi transport. In this article, we characterize the interac-
tion between Sro7 and the type V myosin Myo2 and show that this interaction is important 
for two distinct aspects of Sro7 function. First, we show that this interaction plays a positive 
role in promoting the polarized localization of Sro7 to sites of active growth. Second, we find 
evidence that Myo2 negatively regulates Sro7 function in vesicle clustering. Mutants in either 
Myo2 or Sro7 that are defective for this interaction show hypersensitivity to Sro7 overexpres-
sion, which results in Sec4-dependent accumulation of large groups of vesicles in the cyto-
plasm. This suggests that Myo2 serves a dual function, to both recruit Sro7 to secretory ves-
icles and inhibit its Rab-dependent tethering activity until vesicles reach the plasma membrane. 
Thus Sro7 appears to coordinate the spatial and temporal nature of both Rab-dependent 
tethering and SNARE-dependent membrane fusion of exocytic vesicles with the plasma 
membrane.
INTRODUCTION
Polarized vesicle transport is the product of both the directional 
movement of vesicles toward sites of active growth and the subse-
quent docking and fusion of these vesicles at specific sites of the 
plasma membrane. The directed movement of vesicles involves ves-
icle-associated motor proteins moving along microtubule or actin 
cytoskeletal tracks. Once delivered to the proper site, docking or 
tethering factors bring vesicles into close proximity of the target 
membrane and facilitate subsequent fusion events. The coordination 
of the timing and localization of each of these steps is critical to the 
temporal and spatial specificity of plasma membrane delivery events 
in eukaryotic cells (Vale, 2003; Krendel and Mooseker, 2005).
Rab guanosine 5′-triphosphatases (GTPases) are thought to 
play important roles in coordinating several distinct stages of exo-
cytosis. The budding yeast Saccharomyces cerevisiae has been an 
important model system for dissecting these specific contributions 
(Segev, 2001; Spang, 2004; Grosshans et al., 2006). In particular, 
during post-Golgi transport, two families of Rab GTPases, Ypt31/32 
and Sec4, have been shown to function in vesicle delivery, dock-
ing, and fusion. Active (GTP-bound) Ypt31/32 is important for two 
initial events. First, Ypt31/32 play a role in the recruitment of the 
type V myosin motor Myo2 to secretory vesicles, which is required 
for vesicle delivery along actin cables toward sites of polarized 
growth (Lipatova et al., 2008). Second, Ypt31/32 is necessary for 
recruiting Sec2, a guanine nucleotide exchange factor responsible 
for activating the downstream Rab GTPase Sec4 (Ortiz et al., 
2002). The presence of GTP-bound Sec4 on vesicles is necessary 
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for subsequent vesicle tethering to specific sites on the plasma 
membrane (Salminen and Novick, 1989). The Sec15 subunit of the 
multiprotein exocyst complex acts as a direct effector for Sec4 and 
allows vesicle tethering to the target membrane through its asso-
ciation with members of the exocyst complex at the plasma mem-
brane (Guo et al., 1999; Boyd et al., 2004).
A second effector for the Sec4 GTPase is Sro7, a yeast member of 
the Lgl family of tumor suppressors. Both Sro7 and its homologue, 
Sro77, were initially identified based on their physical association 
with the plasma target membrane SNARE (t-SNARE). Sec9 and, like 
other late-acting sec genes, were shown to be required for efficient 
post-Golgi vesicle docking and fusion (Lehman et al., 1999). Bio-
chemical and structural studies demonstrated that Sro7 has an intra-
molecular autoinhibited interaction with Sec9 that can be “triggered” 
to allow the assembly of active t-SNARE complexes to occur in a 
spatially and temporally restricted manner (Hattendorf et al., 2007). 
In addition to its likely role in soluble N-ethylmaleimide–sensitive 
factor adaptor protein receptor (SNARE)-mediated fusion, Sro7 was 
found to have both biochemical and genetic properties consistent 
with a role as a direct effector for Sec4. Proteomic and biochemical 
analyses with purified proteins demonstrated that Sro7 binds to Sec4 
in a GTP-specific manner. Moreover, overexpression of Sro7 was 
found to suppress a Sec4 effector domain mutant and a number of 
deletions in components of the exocyst complex. Taken together, 
this suggested a role for Sro7 in an effector pathway that functions 
parallel to that of the exocyst complex (Grosshans et al., 2006).
Sro7 has been shown to interact physically with Myo2 (Gangar 
et al., 2005), the type V myosin motor required for post-Golgi vesicle 
transport (Walch-Solimena et al., 1997; Pruyne et al., 1998). Myo2 con-
sists of an N-terminal actin-binding domain, which couples ATP hydro-
lysis to motor activity, and a C-terminal globular tail, which binds to the 
vesicle cargo being transported. Within the central neck region of 
Myo2 lies a coiled-coil domain that is responsible for dimer formation 
and a light chain binding site. Recent work with myosin Va in synaptic 
vesicle transport has suggested that, besides their involvement in 
vesicle transport, type V myosin motors might also affect vesicle matu-
ration and docking at the plasma membrane (Kogel et al., 2010).
In this report we examine the role of Myo2 as both a positive and 
negative regulator of Sro7 function in the cell. We have mapped the 
site of this interaction to precise regions within Myo2 and Sro7 and 
show that Sro7 is recruited to sites of polarized growth through this 
interaction and cells defective in this interaction show loss of secre-
tory function similar to sro7Δ, sro77Δ mutant cells. Interestingly, we 
also show that when the Myo2–Sro7 interaction is disrupted, cells 
become hypersensitive to overexpression of Sro7 and exhibit a 
post-Golgi vesicle clustering phenotype. We show that post-Golgi 
vesicle clustering induced by Sro7 resembles that induced by the 
other characterized effector of Sec4, Sec15. In both cases, post-
Golgi vesicle clustering requires the positive action of Sec4 and is 
independent of downstream Sec9 t-SNARE function. This work sug-
gests a model whereby Sro7 is recruited to post-Golgi vesicles 
through its interaction with Myo2. By binding to Myo2, Sro7 is kept 
inactive until it is delivered to sites of polarized growth, where the 
interaction with Myo2 is relieved, and Sec4-dependent tethering 
with the appropriate membrane can occur.
RESULTS
Mutations in the IQ motifs of Myo2 affect binding to Sro7 in 
vitro and behave like loss-of-Sro7-function mutants in vivo
A previous proteomic analysis of Sro7 (Gangar et al., 2005) identi-
fied Myo2 as one of two major binding partners for Sro7 (the other 
being the t-SNARE Sec9). Myo2 (Figure 1A) has an N-terminal 
motor domain and a C-terminal globular tail region that binds to 
vesicles and other cargo (Johnston et al., 1991; Catlett and Weis-
man, 1998; Schott et al., 1999). The central neck region contains a 
coiled-coil domain that is required for dimer formation (Beningo 
et al., 2000) and an IQ domain that is required for interaction with 
light chains, including myosin light chain 1 (Mlc1) and light chain–
like proteins, such as calmodulin (CaM) (Stevens and Davis, 1998). 
In vitro binding experiments with recombinant portions of Myo2 
suggested that the binding site for Sro7 appeared to reside within 
the Myo2 central neck region (782–990) (Gangar et al., 2005). To 
further delineate the site of interaction within Myo2, we in vitro 
translated smaller elements of the Myo2 neck region that contained 
either the IQ domain (782–925) or the coiled-coil region (871–1204) 
and looked for their ability to bind to purified ProtA-Sro7 bound to 
immunoglobulin (Ig) G beads. The results, shown in Figure 1B, 
demonstrated that the IQ region alone was sufficient to yield strong 
binding to immobilized ProtA-Sro7 bound to IgG beads but not to 
control beads containing ProtA alone. The IQ domain of Myo2 is 
composed of six consecutive repeats of the IQ consensus sequence 
IQXXXRGXXXR, where X represents any amino acid (Johnson et al., 
1991; Bähler et al., 2002). Although deletion of all six IQ motifs re-
sulted in a myosin (myo2-Δ6IQ) that could still support growth (Ste-
vens and Davis, 1998), reductions in the number of the IQ motifs 
were shown to affect the motor function of Myo2 negatively and 
result in a decrease in post-Golgi vesicle transport velocity (Schott 
et al., 2002). To address the ability of Sro7 to interact with the IQ 
domain of Myo2 without affecting the length of the neck region of 
Myo2, we generated point mutations in each IQ domain. The strat-
egy used to generate such mutants is shown in Figure 1C. Within 
each IQ motif, the three highly conserved charged amino acids im-
portant for recognition by light chains Mlc1 and CaM (Li and Sacks, 
2003) were replaced by alanine. The six mutant forms and the wild-
type form of the Myo2-IQ domain (782–925) were in vitro trans-
lated and tested for binding to purified ProtA-Sro7 on beads (Fig-
ure 1C). The results, shown in Figure 1C, demonstrated a 
pronounced effect for the IQ1 mutant and a smaller but statistically 
significant effect for the IQ5 mutant in binding assays with Sro7. We 
also examined the effect of double mutations in the IQ1 and IQ5 
motifs of Myo2 (myo2-iq1,5) and found that this mutant showed 
similar defects as the single myo2-iq1 mutant in the in vitro binding 
assay (Figure 1C).
In contrast, when the identical set of mutant proteins was exam-
ined in binding to recombinant glutathione S-transferase (GST)–
Mlc1, a nonoverlapping set of binding perturbations was found. 
Mutations in IQ3 showed the strongest loss of binding, followed by 
smaller effects with mutations in IQ2 and IQ4. In addition, GST-Mlc1 
showed strong binding to the in vitro–translated tandem IQ repeats 
from yeast Myo1, while Sro7 showed only very weak binding to the 
Myo1 IQ motifs (Figure 1C). Therefore each of Sro7 and Mlc1 
appears to have distinct preferences for particular types of IQ 
repeats in this assay—suggesting a possible means for selectively 
disrupting this interaction in vivo.
To study the in vivo significance of the in vitro binding data, each 
of the MYO2 single IQ mutants and the double IQ mutant (myo2-
iq1,5) were transformed into yeast as the only source of Myo2 in the 
cell. Each of the IQ domain mutants described above was intro-
duced into yeast by replacement of the myo2-Δ6IQ in a heterozygous 
diploid strain by homologous recombination (see Materials and 
Methods). Diploids were sporulated and subjected to tetrad analy-
sis to identify haploids with the IQ mutations as the sole copy of 
MYO2 in the cell. While the individual iq mutants showed little effect 
on growth under the conditions tested, the combination of the iq1 
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and iq5 mutation (myo2-iq1,5) showed a dramatic loss of growth at 
low temperatures (Figure 1D)—a phenotype similar to that of sro7Δ, 
sro77Δ yeast in response to cold (Lehman et al., 1999). The synthetic 
effect of the combination of the IQ1 and IQ5 mutations observed in 
vivo is more severe than that observed in vitro, perhaps reflecting 
functional redundancy for these sites in vivo. Moreover, the in vitro 
FIGuRE 1: Identification of myo2-iq1,5, a novel myosin mutant that phenocopies a loss of Sro7 function. (A) Schematic 
representation of the type V motor, Myo2. (B) Minimum domain required for binding to Sro7. Radiolabeled fragments of 
the neck region of Myo2 were obtained by in vitro translation and bound to purified protASro7 on beads. (C) Strategy 
for generating point mutations in the IQ motif and effects of such mutations on binding to Sro7. Alanine substitutions 
made are shown in red. Charts show the results of binding assays between radiolabeled wild-type Myo2 (782–990) or 
Myo2 mutants (782–990) and protASro7 or control GST-Mlc1 on beads. Error bars represent the SD from three 
independent experiments. Binding of the IQ region of Myo1 (761–932) is shown on the extreme right of each chart as a 
comparison. (D) Three individual colonies of haploid yeast containing mutations in the IQ domain of Myo2 were picked 
into microtiter wells, transferred to YPD at the indicated temperatures and salt concentrations, and compared with 


































































































































140C 5days 140 C 8days
320C
YPD
IQ1 IQ2 IQ3 IQ4 IQ5 IQ6
Volume 22 March 15, 2011 Myo2 regulation of Sro7 function in vesicle clustering | 845 
binding data may not precisely reflect the in vivo situation due to 
the lack of competition from other IQ interacting proteins such as 
Mlc1. In addition to cold sensitivity, a second hallmark of loss of 
Sro7/77 function in yeast is sensitivity to high-sodium salts but not 
high-potassium salts (Larsson et al., 1998). We therefore examined 
the effects of the iq mutants on yeast peptone dextrose (YPD) media 
with 0.7 M KCl and 0.7 M NaCl. The results, shown in Figure 1D, 
revealed that, like the sro7Δ mutant, the myo2-iq1,5 mutant exhibits 
dramatic growth defects on YPD plates containing 0.7 M NaCl but 
not on 0.7M KCl. As with the cold sensitivity, none of the individual 
iq alleles showed any significant growth defect in high salt, suggest-
ing that in vivo both IQ motifs function redundantly in their interac-
tion with Sro7. Taken together these data suggest that the mutant 
form of Myo2, which demonstrates a specific defect in binding to 
Sro7 in vitro, exhibits phenotypes similar to those seen when Sro7 
function is compromised in vivo. Therefore the phenotypes ob-
served in the myo2-iq1,5 mutant strongly suggest that Myo2 plays 
an important role in the regulation of Sro7 function in vivo.
The myo2-iq1,5 mutant displays a cold-sensitive defect in 
post-Golgi secretion
Analysis of the growth properties of the myo2-iq1,5 mutant in liquid 
culture demonstrated a dramatic growth defect at 25°C when com-
pared with growth at 32°C (Figure 2A, Figure 1D). We have previ-
ously shown that loss of Sro7 function is accompanied by the accu-
mulation of post-Golgi secretory vesicles and defects in secretion of 
invertase and Bgl2 (Lehman et al., 1999; Hattendorf et al., 2007). We 
therefore examined the secretory function of myo2iq-1,5 strains 
grown at permissive temperature (32°C) or after an 8-h shift to the 
nonpermissive temperature (25°C). As a positive control we used a 
well-characterized secretory mutant, sec4P-48, which acts at the 
same stage of the pathway and shows growth and secretion defects 
in the same temperature range as myo2-iq1,5 (Brennwald et al., 
1994). Results from the secretion assays (Figure 2B) showed that 
there was a clear defect in Bgl2 secretion and a small, but signifi-
cant, effect on invertase secretion upon a shift to the restrictive tem-
perature in the myo2iq-1,5 strain. Moreover, the accumulation cor-
related with a dramatic increase in the penetrance and number of 
post-Golgi vesicles (80–100 nm in size) observed within the bud and 
the mother cell imaged by thin-section electron microscopy 
(Figure 2C). Quantitation of the penetrance of this effect demon-
strated that the myo2-iq1,5 mutant showed 56% of cells with greater 
than 10 vesicles at 25°C, while only 19% of the mutant cells exhib-
ited greater than 10 vesicles at 32°C. As expected, none of the 
isogenic wild-type cells showed vesicle accumulation at either tem-
perature (Supplemental Figure 1). Therefore, like the sro7Δ, sro77Δ 
mutant, the myo2iq-1,5 mutant shows a cold-sensitive defect in 
growth and post-Golgi secretion.
Sro7 polarization is lost in the myo2-iq1,5 mutant strain
To look for possible effects of the myo2iq-1,5 mutant on the subcel-
lular localization of Sro7, we generated a tagged form of Sro7 con-
taining three tandem copies of green fluorescent protein (GFP) in-
serted at the N-terminus (Supplemental Figure 2) of the Sro7 coding 
sequence. Attempts to fuse GFP at the C-terminus of the protein 
resulted in loss of function (scored by complementation of the sro7Δ, 
sro77Δ mutant), as this region is essential (Hattendorf et al., 2007). 
Three copies of GFP were required to detect Sro7 expressed behind 
its own promoter from a single-copy (CEN) plasmid. The GFP-tagged 
SRO7 fully complemented both the cold sensitivity and salt sensitiv-
ity of the sro7Δ, sro77Δ strain, suggesting that the introduction of a 
GFP tag at the N-terminus of the protein did not affect function 
(Supplemental Figure 2). Western blot analysis of whole-cell extracts 
from cells containing the GFP-SRO7 allele expressed a protein of the 
expected mobility that was present at levels just slightly above (2.5×) 
that of the endogenous Sro7 protein (Supplemental Figure 2). As 
shown in Figure 3A, GFP-Sro7 was concentrated in the bud of grow-
ing cells and at sites of division in cells undergoing cytokinesis.
To study whether polarized localization of Sro7 requires the inter-
action with the IQ domain of Myo2, wild-type and myo2-iq1,5 mu-
tant cells were transformed with GFP-Sro7 and examined by fluores-
cence microscopy. Overall polarity in the myo2-iq1,5 mutant was 
monitored by comparing GFP-Sro7 polarization to that of GFP-Sec4 
introduced under identical conditions into the mutant strain, as polar-
ization of the Sec4 GTPase is known to be affected rapidly by a per-
turbation of Myo2-dependent vesicle transport (Pruyne et al., 1998). 
GFP-Mlc1 was also transformed in both wild-type and mutant myo2-
iq1,5 cells to determine whether the specificity of the IQ1 and IQ5 
mutations was through an effect on Sro7 and not by perturbing the 
polarization of the Myo2 myosin light chain, Mlc1. The results in Fig-
ure 3B show a remarkably specific effect of the myo2-iq1,5 mutant on 
polarity of Sro7. GFP-Sec4 and GFP-Mlc1 fluorescence in the myo2-
iq1,5 mutant strain was comparable to the wild type. However, under 
these same conditions, GFP-Sro7 did not localize to sites of polarized 
growth and appeared diffuse in ∼95% of the small budded cells ana-
lyzed. Coimmunoprecipitation experiments with MYO2 or myo2-
iq1,5 strains demonstrated that while Sro7 could readily be detected 
in anti-Myo2 immunoprecipitations, we failed to see any detectable 
coimmunoprecipitation of Sro7 from myo2-iq1,5 cells (Figure 3C). 
Taken together, these results indicate that mutations in the IQ region 
of Myo2 that disrupt Sro7 binding in vitro also disrupt the association 
in vivo and have a highly selective effect on the polarized localization 
of GFP-Sro7 without affecting the overall polarity of the cell. More-
over, these data suggest that the loss of Sro7 polarization in these 
cells may be responsible for the cold-sensitive secretory phenotypes 
observed in the myo2iq-1,5 mutant strain (Figure 2, B and C).
Sro7 polarization appears to be the product of delivery on 
post-Golgi vesicles
Many components of the late secretory apparatus have a polarized 
staining pattern similar to that seen for Sro7—including the Sec4 
GTPase, the Sec4 exchange factor Sec2, and components of the 
exocyst complex (Goud et al., 1988; Walch-Solimena et al., 1997; 
Boyd et al., 2004). In each of these cases, the observed localization 
was found to be mediated by a Myo2-dependent polarized delivery 
of vesicles along actin cables. To address the possibility of the Myo2-
dependent pathway for Sro7 polarization, we first examined the de-
gree of colocalization between GFP-Sro7 and the vesicle marker red 
fluorescent protein (RFP)–Sec2 in strains coexpressing both markers. 
For these results we focused on fixed cells where discrete RFP-Sec2 
particles (which in live cells are seen to move toward sites of growth) 
were clearly visible. The results, shown in Figure 4A, showed a high 
degree of colocalization (85%) of GFP-Sro7 with RFP-Sec2, support-
ing the possibility that Sro7 is associated with the Sec4/Sec2/Myo2 
system of vesicle delivery. There is still, however, a significant frac-
tion of Sec2-containing particles in which Sro7 is not detectable, as 
only 58% of the total RFP particles colocalized with the GFP parti-
cles. To determine whether the polarized staining of GFP-Sro7 was 
dependent on the Sec4/Sec2/Myo2 post-Golgi vesicles delivery 
system, we examined the fate of GFP-Sro7 in mutants in this deliv-
ery system. For example, polarized Sec4 delivery is known to be lost 
in myo2-66 and sec2-41 mutants, but it remains polarized in a sec6-4 
mutant, which is required for vesicle docking and not polarized 
delivery (Walch-Solimena et al., 1997; Pruyne et al., 1998). We 
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FIGuRE 2: The myo2-iq1,5 mutant shows a pronounced cold-sensitive secretory defect in post-Golgi transport.  
(A) Wild-type and the myo2-iq1,5 mutant were grown at the permissive temperature of 32°C and then shifted to the 
restrictive temperature of 25°C. Growth at both temperatures was monitored at 3-h intervals in YPD media. (B) Graphs 
show results of invertase and Bgl2 assays conducted on wild-type, myo2-iq1,5, and the sec4-P48 mutants after a shift to 
the restrictive temperature of 25°C for 8 h. Error bars represent the SD from three independent experiments.  
A representative blot of a Bgl2 assay is shown. (C) myo2-iq1,5 cells grown under permissive conditions (32°C) or grown 
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FIGuRE 3: GFP-Sro7 polarization to sites of active growth is dramatically perturbed in the 
myo2-iq1,5 mutant. (A) Wild-type strain expressing GFP-Sro7 (CEN) was grown in selective 
media to midlog at 25°C and then fixed and processed for fluorescence microscopy. Bar, 1 μm. 
(B) Wild-type and myo2-iq1,5 strains expressing GFP-Sro7 (CEN), GFP-Sec4 (CEN), and 
GFP-Mlc1 (CEN) were grown in selective media at the permissive temperature (32°C) and then 
fixed and processed for fluorescence microscopy. Quantitation of polarized tagged proteins in 
wild-type and myo2-iq1,5 mutant cells were obtained by scoring a minimum of 50 cells at 
emerging bud sites and bud tips. Bar, 1 μm. (C) Wild-type and myo2-iq1,5 mutant cells were 
grown overnight at permissive temperature (32°C) and then shifted to 25°C for 8 h before being 
spheroplasted, lysed, and subjected to immunoprecipitation with affinity-purified preimmune 
(pi) and immune (i) anti-Sro7 and anti-Myo2 antibody. The lane marked T represents the input of 
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therefore examined the effect of sec6-4, myo2-66, and sec2-41 mu-
tants on the localization of GFP-Sro7 following a shift to the restric-
tive temperature. The results, shown in Figure 4B, demonstrate that 
while GFP-Sro7 maintains its polarity in sec6-4 and wild-type cells, 
polarity is drastically lost in the myo2-66 and sec2-41 mutant back-
grounds. This result is identical to the effects of these mutants on 
Sec4 localization and suggests that Sro7 is brought to sites of polar-
ized growth by delivery with post-Golgi vesicles.
Sro7 forms large clusters of post-Golgi vesicles in the 
myo2-iq1,5 mutant when expressed from a moderate 
promoter
When overexpressed, Sro7 is able to rescue a number of mutants 
defective in the late secretory pathway, including cdc42-6, rho3-V51, 
sec4-P48, sec3-2, sec8-9, and sec15-1 
(Lehman et al., 1999; Adamo et al., 2001). 
To understand whether increasing the ex-
pression of Sro7 in the myo2-iq1,5 strain 
would rescue the growth defect observed in 
this mutant, we transformed wild-type and 
the myo2-iq1,5 strain with a plasmid that ex-
pressed Sro7 from a tetracycline-repressible 
promoter. This promoter is repressed in the 
presence of doxycycline, and in the absence 
of doxycycline it increases the level of Sro7 
approximately five times over the level of 
endogenous Sro7. As expected, the pres-
ence of the tet-Sro7 plasmid strongly sup-
pressed the temperature-sensitive growth 
defect of sec15-1 strains grown in the ab-
sence of doxycycline but failed to suppress 
in the presence of doxycycline (Figure 5A). 
This plasmid did not affect growth in wild-
type cells. To our surprise we found that the 
myo2-iq1,5 mutant was not suppressed by 
Sro7 overexpression but rather demon-
strated a strong doxycycline-dependent in-
hibition of growth that was most apparent at 
25°C (Figure 5A).
To understand the dominant negative ef-
fect of Sro7 overexpression on myo2-iq1,5 
cells, we transformed these strains with a 
plasmid expressing GFP-Sec4 (CEN) and ex-
amined Sec4 localization by fluorescence 
microscopy. Like Sec2, GFP-Sec4 is an abun-
dant marker for the vesicle delivery system 
in yeast (Pruyne et al., 1998) and is found 
associated with sites of polarized growth. 
Following induction of Sro7, the distribution 
of GFP-Sec4 changed drastically and ap-
peared as large “patches” in the cytoplasm 
(Figure 5B). When we examined these cells 
by thin-section electron microscopy, we 
found the appearance of large clusters of 
80–100 nm vesicles (Figure 5C). Quantita-
tion of the electron micrographs demon-
strate that 92% of the TET-SRO7/myo2-iq1,5 
cells exhibited vesicle clusters, while only 
7% of the TET-SRO7/MYO2 cells and 12.5% 
of the TET empty vector/myo2-iq1,5 cells 
exhibited vesicle clustering. No cells were 
observed with vesicle clusters in the empty 
vector control/MYO2 combination. Therefore myo2-iq1,5 cells ap-
pear to be specifically sensitive to moderate overexpression of Sro7 
in the tet-repressible expression system. This sensitivity is seen as 
an effect on growth and vesicle patch formation, observed by both 
fluorescence and electron microscopy. This phenomenon is remark-
ably similar to the effect of overexpression of another well-charac-
terized Sec4 effector protein, Sec15, suggesting that vesicle cluster-
ing may be a common feature of overregulation of Sec4 function in 
membrane tethering (Salminen and Novick, 1989).
Sro7 and Sec15 cause Sec4-dependent vesicle clustering 
when expressed under a strong promoter in wild-type cells
Previous work describing the vesicle clustering property of Sec15 
overexpression made use of a strong inducible GAL1/10 promoter. 
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GAL-SEC15 showed a strong inhibition of growth in wild-type yeast 
but not in sec4-8 or sec2-41 mutants (Salminen and Novick, 1989), 
suggesting that a functional Rab (Sec4) is required in order to in-
duce vesicle clustering and growth inhibition. To directly compare 
effects of the two Sec4 effector proteins on vesicle clustering, both 
open reading frames of Sro7 and Sec15 were put under the control 
of the strong galactose-inducible promoter and transformed into 
wild-type stains and various late sec mutant strains by integrative 
transformation. As seen previously, the GAL-SEC15 transformants 
exhibited a severe inhibition of growth in wild-type and sec9-4 
strains when grown on galactose-containing media (Figure 6A). In 
contrast, no growth inhibition was observed in the sec2-41 or sec4-
8 mutants, as previously reported (Salminen and Novick, 1989). 
Interestingly, we saw a strikingly similar pattern when GAL-SRO7 
was introduced into wild-type and the same set of secretory 
mutants: sec9-4, sec2-41, and sec4-8 (Fig-
ure 6A). Quantitative Western blot analysis 
suggests that the level of overexpression of 
Sro7 is ∼16 times over the endogenous 
level following a 10-h induction (Fig-
ure 6B)—similar to the levels of overexpres-
sion reported for GAL-SEC15 (Salminen 
and Novick, 1989). The similar pattern of 
growth arrest for GAL-SRO7 and GAL-
SEC15 suggests that the overexpression of 
these Rab effectors might result in a related 
effect on post-Golgi trafficking downstream 
of Sec4. We therefore examined the GAL-
SRO7– and GAL-SEC15–induced cells by 
thin-section electron microscopy. As previ-
ously observed, the GAL-SEC15 strain 
showed a highly penetrant (70%) pheno-
type, where large clusters of 80–100 nm 
vesicles were present that were not ob-
served in control wild-type cells (Figure 6C). 
Interestingly, we observed a nearly identi-
cal, highly penetrant (76%) accumulation of 
clusters of 80–100 nm vesicles in response 
to GAL-SRO7 expression (Figure 6C). The 
striking similarity of growth and vesicle clus-
tering phenotypes observed for these two 
Sec4 effectors strongly suggests that they 
occur through a common Sec4-dependent 
mechanism.
To further characterize the clustering of 
post-Golgi vesicles induced by GAL-SEC15 
and GAL-SRO7, we analyzed vesicle cluster 
formation by immunofluorescence micros-
copy using monoclonal antibodies to the 
post-Golgi vesicle marker, Sec4, and poly-
clonal antibodies to either Sro7 or Sec15. As 
seen in Figure 7 (A and B), conditions that 
led to vesicle cluster formation by electron 
microscopy correlated with the formation of 
a large patch of Sec4 staining within the cell, 
which differed significantly from polarized 
Sec4 staining (i.e., bud tips) in cells with no 
Sro7 or Sec15 overexpression. Consistent 
with the notion that the formation of the 
Sec4 patch is tightly linked to the growth ar-
rest seen in Figure 6A, Sec4 patches were 
not observed in the sec4-8 or sec2-41 mu-
tants, suggesting that activated GTP-bound Sec4 is required for 
GAL-SEC15 and GAL-SRO7 to induce vesicle clusters in the cell. As 
seen previously (Salminen and Novick, 1989), overexpression of 
Sec15 results in pronounced accumulation of Sec15 staining by im-
munofluorescence that colocalizes precisely with the Sec4 patches 
that form in these cells (Figure 7A). Likewise we find that overexpres-
sion of Sro7 results in a pronounced accumulation of Sro7 staining in 
patches that colocalize precisely with Sec4 (Figure 7B). Therefore 
both Sec4 effectors appear to be physically associated with the 
vesicle clusters that they induce.
The N-terminal 13 amino acids of Sro7 are required for 
Myo2 binding and Sro7 polarization
As described above, myo2-iq1,5 mutants show increased sensitiv-
ity to Sro7 such that even moderate overexpression from a 
FIGuRE 4: Sro7 polarization appears to be the product of delivery on post-Golgi vesicles. Cells 
expressing both GFP-Sro7 (CEN) and RFP-Sec2 (CEN) were grown in selective media overnight 
and then fixed and processed for fluorescence microscopy. The merged image of GFP-Sro7 and 
RFP-Sec2 fluorescence is shown on the right. Bar, 1 μm. (D) Wild-type, sec6-4, sec2-41, and 
myo2-66 mutant strains containing GFP-Sro7 were grown in selective media to midlog at 25°C 
and then shifted to 37°C for 1 h before fixing and processing for fluorescence microscopy. 
Quantitation of GFP-Sro7 polarization was obtained by scoring a minimum of 50 cells for the 





























WT sec6-4 sec2-41 myo2-66
GFP RFP
Volume 22 March 15, 2011 Myo2 regulation of Sro7 function in vesicle clustering | 849 
tet-inducible promoter results in vesicle clustering and a pronounced 
inhibition of growth. This suggests a simple model in which the in-
teraction between Myo2 with Sro7 helps to negatively regulate 
Sec4-dependent vesicle tethering. To further examine this model, 
we sought to identify the site of interaction on Sro7 that binds the 
IQ domains of Myo2. Previous work using chimeric swaps between 
Sro7 and mammalian Lgl (Gangar et al., 2005) have demonstrated 
that neither the two WD propeller motifs nor the C-terminal do-
main of Sro7 is required for this interaction. Because these con-
structs contain the N-terminal 45 residues of Sro7 (Gangar et al., 
2005), we examined whether this region might contain the binding 
site for Myo2. Within this region, only the extreme N-terminus 
(4–18 in Sro7) shows conservation with Sro77 and other related as-
comycetes members (Figure 8A). We therefore examined the bind-
ing of in vitro–translated Sro7, with large or small deletions in the 
N-terminus, to recombinant GST-Myo2IQ (782–990). As a positive 
control, a recombinant full-length 
form of the t-SNARE protein, Sec9, 
was used. Figure 8B shows that 
all of the mutant forms of Sro7 
bound well to the t-SNARE, Sec9, 
as predicted by previous work 
(Hattendorf et al., 2007). In con-
trast, while full-length Sro7 binds 
well to GST-Myo2IQ, both the 
large (Sro7-Δ[3–51]) and small 
(Sro7-Δ[4–18]) N-terminal dele-
tions of Sro7 resulted in significant 
loss of interaction with GST-
Myo2IQ. Therefore the conserved 
region within the extreme N-
terminus of Sro7 appears to be 
required for binding to Myo2.
Because the data presented 
above suggest that the interaction 
of Sro7 with Myo2 is critical for the 
ability of GFP-Sro7 to be delivered 
to sites of polarized growth, we ex-
amined the effect of deleting this 
putative binding site on the polar-
ization of GFP-Sro7. The result of 
this experiment, shown in Fig-
ure 8C, demonstrated that while 
the wild-type GFP-Sro7 protein is 
highly polarized, the N-terminal 
deletion mutant GFP–Sro7-Δ(4–18) 
showed diffuse cytoplasmic fluo-
rescence and a loss of polarized 
localization at the bud tip. Consis-
tent with the N-terminus of Sro7 
being critical for the physical asso-
ciation between Myo2 and Sro7, 
when we examine the ability of 
wild-type and Sro7-Δ(3–51) pro-
teins to coimmunoprecipitate with 
Myo2, we find that the mutant pro-
tein cannot detectably associate 
(Figure 8D). Taken together with 
the in vitro binding data, this ex-
periment strongly supports the no-
tion that the extreme N-terminus 
of Sro7 is required for its interac-
tion with Myo2. Moreover, the similarity of this phenotype to that 
seen for wild-type GFP-Sro7 in the myo2-iq1,5 mutant demonstrates 
the importance of the interaction with Myo2 for polarization of 
Sro7.
A predicted consequence of generating a form of Sro7 with re-
duced ability to interact with Myo2 is that it may result in a protein 
that would behave similarly to that of wild-type Sro7 in a myo2-iq1,5 
mutant background, where even moderate overexpression results in 
severe growth inhibition and vesicle clustering. Therefore we intro-
duced the N-terminal mutant forms of Sro7 in the tet-repressible 
expression system and examined their effect when expressed in 
wild-type and several exocyst mutant backgrounds (sec15-1, sec8-9, 
and exo70-113). The results shown in Figure 8E demonstrate that, 
while dominant effects on growth were not apparent in wild-type 
cells, severe dominant effects on growth were apparent in response 
to the N-terminal deletion in three exocyst mutant strain backgrounds. 
FIGuRE 5: Sro7 forms large clusters of post-Golgi vesicles when expressed in the myo2iq-1,5 mutant 
under a moderate promoter. (A) Wild-type, myo2-iq1,5, and sec15-1 mutant cells were transformed with a 
plasmid expressing Sro7 behind a tetracycline-repressible promoter (CEN) or vector only. Four 
independent transformants were picked into microtiter wells and transferred to YPD in the presence or 
absence of doxycycline. (B) Wild-type and myo2-iq1,5 mutant cells containing a Sro7 behind a 
tetracycline-repressible promoter (CEN) were transformed with GFP-SEC4 (CEN). Cells were grown in 
selective media in the presence of doxycycline and then shifted to media lacking doxycycline to induce 
Sro7 expression for 8 h at 25°C. Cells were then fixed and processed for fluorescence microscopy (bar, 
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All dominant growth effects were lost in the presence of doxycy-
cline, and no dominant effects on growth were observed for wild-
type Sro7 expressed in any of these strains. The lack of a dominant 
effect for the N-terminal deletion mutants on wild-type cells might 
be a consequence of having a fully functional exocyst complex in 
these strains. Taken together it is apparent that loss of the site of 
Myo2 interaction within Sro7 generates a form of the protein that 
phenocopies many of the effects of the loss of the Sro7:Myo2 inter-
action in the myo2-iq1,5 mutant. Importantly, the lethality induced 
by the N-terminal truncations of Sro7 in the exocyst mutant back-
grounds (sec15-1 and exo70-113) correlates strongly with the ap-
pearance of Sec4-positive clusters in these cells, which are likely to 
represent clusters of post-Golgi vesicles (Figure 8F). This strongly 
supports the model that loss of Myo2 binding leads to an up-regu-
lation of Sro7 function, leading in turn to the membrane (vesicle) 
clustering phenotypes observed here.
Because Myo2 and Sec4 appear to function in opposite direc-
tions with regard to Sro7 function in vesicle clustering, we hypoth-
esized that binding of Myo2 to Sro7 may directly or indirectly ef-
fect binding of Sro7 to Sec4-GTP. To examine this notion directly, 
we tested the effect of adding the purified Myo2 neck region (con-
taining the six IQ repeats and the coiled-coil domain) on the bind-
ing of purified full-length Sro7 to Sec4-GTP in an in vitro binding 
assay (Grosshans et al., 2006). As a control we used the Myo2 neck 
region containing the IQ1 and IQ5 alanine point mutants described 
above. As we previously observed (Grosshans et al., 2006), we find 
the binding of Sro7 to Sec4 is highly dependent on the GTP-bound 
conformation of Sec4, as we see greater than fivefold stimulation 
in binding to GTPγS-bound Sec4 compared with guanosine 
5′-diphosphate (GDP)–bound Sec4 (Figure 9). When we add 4 μM 
Myo2 neck region to the binding reaction, we see a 50% inhibition 
in the binding of Sro7 to Sec4-GTP. In contrast, no significant inhi-
bition of binding was observed when 4 μM Myo2-IQ1,5 mutant 
protein was added to the binding assay. Therefore Myo2 not only 
antagonizes Sec4-Sro7 activity genetically but also antagonizes 
the physical interaction between Sro7 and Sec4 biochemically. This 
suggests a simple model (shown in Figure 9B) for the temporal and 
spatial regulation of Sro7 activity by Myo2, in which following its 
initial recruitment to the vesicle surface by Myo2, Sro7 would be 
maintained in an inactive form inaccessible for activation by the 
Rab GTPase, Sec4. Once arriving at the appropriate docking site, 
Myo2 would be displaced from Sro7 (by an as yet unknown mech-
anism—perhaps simply by high concentration of GTP-Sec4), and 
Sec4-GTP binding and activation of Sro7 would proceed—allow-
ing docking and subsequent SNARE assembly and fusion to 
occur.
FIGuRE 6: Sec15 and Sro7 drive formation of clusters of post-Golgi vesicles in wild-type cells when expressed from a 
strong promoter. (A) Vesicle clustering is Rab dependent and Sec9 t-SNARE independent. Wild-type, sec4-8, sec2-41, 
and sec9-4 mutant strains were transformed with GAL-SRO7 (Yip) or GAL-SEC15 (Yip). Four individual colonies were 
picked into microtiter wells and then transferred onto YP plates containing dextrose or galactose. (B) Glass bead lysis 
and Western blot analyses was conducted to compare expression levels of Sro7 using anti-Sro7 and anti-Sso (control) 
rabbit polyclonal antibodies. (C) Wild-type strains expressing Sec15 or Sro7 from the galactose-inducible promoter (YIP) 
were grown in raffinose and then induced in galactose for 10 h at 25°C before fixing and processing for electron 
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suggest that this interaction plays both positive and negative regu-
latory roles in modulating Sro7 function in polarized exocytosis. Al-
leles of MYO2 encoding point mutations that selectively disrupt the 
interaction with Sro7 show specific defects in polarization of 
DISCUSSION
In this article we characterize the cell biological, biochemical, and 
genetic significance of the interaction between the type V myosin 
Myo2 and the yeast lethal giant larvae homologue Sro7. Our data 
FIGuRE 7: Overexpression of Sec15 or Sro7 correlates with the appearance of a bright patch of Sec4 in the cell. 
Wild-type, sec9-4, and sec4-8 strains transformed with (A) GAL-SEC15 (YIP) or (B) GAL-SRO7 (YIP) were grown in 
raffinose and then induced with galactose for 10 h at 25°C. Cells were then fixed for immunofluorescence microscopy 
and analyzed with monoclonal anti–mouse Sec4 antibodies and polyclonal anti–rabbit Sec15 or Sro7 antibodies. Bar 1 μm.
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FIGuRE 8: The N-terminal domain of Sro7 is required for the interaction with Myo2. (A) Alignment of the 
N-terminal region of Sro7 and Sro77 Lgl family members. (B) Deletion of the N-terminal domain of Sro7 affects 
binding to Myo2. Binding of radiolabeled, in vitro–translated full-length and N-terminal truncations of Sro7 to 
GST-Myo2IQ and GST-Sec9 on beads. (C) Wild-type cells expressing GFP-Sro7 (CEN) or GFP–Sro7-Δ(4–18) (CEN) 
were grown to midlog in selective media and then observed by fluorescence microscopy. Quantitation was 
obtained by scoring >50 cells for the presence of GFP fluorescence at emerging bud sites and bud tips. Bar 1 μm. 
(D) Wild-type cells expressing Sro7 or Sro7-Δ(3–51) behind a tetracycline-repressible promoter (CEN) were 
spheroplasted, lysed, and subjected to immunoprecipitation with affinity-purified preimmune and anti-Myo2 
antibody. (E) Wild type, sec15-1, sec8-9, and exo70-113 were transformed with a plasmid expressing Sro7, 
Sro7-Δ(3–51), or Sro7-Δ(4–18) behind a tetracycline-repressible promoter (CEN) or vector only. Four independent 
transformants were picked into microtiter wells and transferred to selective media in the presence or absence of 
doxycycline at different temperatures. (F) sec15-1 mutant cells transformed with a plasmid expressing Sro7, 
Sro7-Δ(3–51), or vector only were grown at 25°C in the presence of doxycycline and then shifted to media without 
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results in cells that are unable to properly polarize Sro7, thus result-
ing in cold-sensitive and salt-sensitive growth and secretion defects 
similar to those observed with loss of Sro7/77 function. These results 
GFP-Sro7 and show growth defects that are strikingly similar to 
those observed in sro7Δ, sro77Δ null mutants. These phenotypes 
are consistent with the notion that loss of Sro7 interaction with Myo2 
FIGuRE 9: (A) The neck region containing the IQ motif of Myo2 is inhibitory to Sro7 binding to GTP bound Sec4. In 
vitro binding assays were conducted with GDP- or GTPγS-loaded Sec4 immobilized on glutathione Sepharose beads, 
soluble Sro7 (1 μM) and soluble wild-type IQ region of Myo2 (4 μM), or mutant Myo2IQ1,5 (4 μM). Graph shows results 
from four independent experiments, and SD and a Student’s t test showed a p value < 0.016. (B) Model for the 
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stems from the fact that we find that both the myo2-iq1,5 mutant 
(Figure 3) and the sro7Δ/sro77Δ mutant (Gangar et al., 2005) show 
normal polarization of Sec4 at sites of polarized growth—a pheno-
type that is known to be highly sensitive to Myo2-dependent vesicle 
delivery (Walch-Solimena et al., 1997).
Previous work on Sro7 has characterized its role as an important 
regulator of SNARE complex assembly at sites of polarized growth 
at the plasma membrane. These results, however, highlight a novel 
role for Sro7 as a Rab-dependent tethering factor that acts in paral-
lel to the exocyst complex. The data presented in this article sug-
gest that, during polarized growth, Rab effector function must be 
tightly regulated and kept inactive until the vesicle is at the appro-
priate site on the correct target membrane. The type V myosin Myo2 
may play such a role in the temporal and spatial regulation of Sro7 
function. In such a model (Figure 9), Myo2 would help to recruit Sro7 
to the surface of post-Golgi vesicles, but Sro7 would remain in a 
form that is inactive in promoting membrane tethering. On arrival to 
the target membrane, the inhibitory action would be relieved by 
displacement of Myo2 from Sro7, allowing Sec4- and Sro7-dependent 
tethering to the plasma membrane to occur. Displacement of Myo2 
from Sro7 could occur through a number of possible triggering 
events. For example, interaction of Sro7 with the t-SNARE Sec9, the 
exocyst subunit Exo84, or both could represent displacement fac-
tors. Displacement activity could function through factors binding to 
a site on Sro7 that overlaps with that of Myo2, or through binding to 
a different site on Sro7 that induces a conformational change, pre-
venting the N-terminus of Sro7 from being available for Myo2 bind-
ing. If the displacement factors were localized at higher concentra-
tions to sites of polarized growth, such a mechanism may represent 
an important means of increasing the temporal and spatial specific-
ity of vesicle-tethering reactions. Such a mechanism would aid not 
only in preventing vesicle:vesicle clustering but also in ensuring that 
tethering was unlikely to occur at inappropriate membranes.
Previous studies have demonstrated strong genetic interactions 
between Lgl homologues and both type II and type V myosins in 
flies and yeast (Kagami et al., 1998; Peng et al., 2000). In fly neuro-
blasts, Lgl and type II myosins appear to act antagonistically to each 
other in promoting polarized localization of cell fate determinants 
(Peng et al., 2000). Likewise, antagonistic genetic interactions were 
observed between yeast Sro7 and type II myosin during cytokinesis 
(Kagami et al., 1998). Therefore the negative regulatory role we ob-
serve here for Myo2 on Sro7 may utilize a conserved mechanism by 
which myosin motor proteins regulate Lgl family protein function in 
promoting cell polarity. In this way the regulatory interactions de-
scribed in this work may be part of an ancestral mechanism for regu-
lation of eukaryotic cell polarity through localized regulation of Lgl 
function. Further analysis of myosin-Lgl in other systems may be 
necessary to determine whether this is the case.
MATERIALS AND METHODS
Media and reagents
Strains were grown in either YP medium (1% bacto-yeast extract and 
2% bacto-peptone; Difco, Sparks, MD), S minimal media (0.67 yeast 
nitrogen base; Difco, Sparks, MD), or dropout media lacking the ap-
propriate amino acid (0.67 yeast nitrogen base with amino acid sup-
plement; US Biological, Swampscott, MA) with 2% glucose. Strains 
for galactose inductions were grown in 3% raffinose and induced 
with 1% galactose (US Biological, Swampscott, MA). Nourseothricin 
sulphate was obtained from Sigma-Aldrich, St. Louis, MO. G418 sul-
phate was obtained from US Biological. Doxycycline hyclate was 
obtained from Sigma Aldrich, St. Louis, MO. Zymolyse 100T was ob-
tained from Seikagaku America, Falmouth, MA. GTPγS was from 
strongly suggest that Myo2 has a positive role in promoting the 
polarity and overall function of Sro7 in exocytosis by aiding in the 
delivery of Sro7 to sites of active growth. A negative regulatory role 
of Myo2 on Sro7 became clear when we tried to determine whether 
moderate overexpression of Sro7 could suppress the growth de-
fects associated with the myo2-iq1,5 mutant. Previous work demon-
strated that Sro7 overexpression was capable of suppressing a num-
ber of late-acting sec genes (Lehman et al., 1999; Zhang et al., 2005; 
Grosshans et al., 2006). However, rather than suppressing the cold-
sensitive and salt-sensitive growth defects associated with the 
myo2-iq1,5 mutant, even moderate overexpression of Sro7 (using 
the tetracycline-repressible promoter) exhibited severe growth de-
fects in the myo2-iq1,5 mutant. This hypersensitivity to moderate 
Sro7 overexpression was not observed in wild-type cells and was in 
contrast to the ability of this same tet-repressible Sro7 construct to 
strongly suppress several late-acting sec mutants.
Interestingly, we found that the negative effect of Sro7 overex-
pression on growth correlated precisely with the appearance of 
post-Golgi vesicle “clusters” using both fluorescence and electron 
microscopy. Additional evidence for this negative mode of regula-
tion appeared when we examined mutant forms of Sro7 that were 
defective in binding to Myo2. We found that moderate overexpres-
sion of Sro7 mutants defective in Myo2 binding induced dominant 
negative growth defects when expressed in several late-acting 
secretory mutants. These growth defects were also associated with 
the formation of vesicle clusters, suggesting that this is a common 
readout when Sro7 function is increased in the absence of Myo2 
regulation.
The post-Golgi vesicle clustering phenotype we observed with 
increasing Sro7 function and/or loss of negative regulation by Myo2 
has features that suggest the clustering phenomenon may be func-
tionally related to post-Golgi vesicle tethering that normally occurs 
at the plasma membrane. First, the clustering phenomena—like 
many vesicle-tethering reactions examined in vitro (Pfeffer, 
1999)—requires both a fully functional Rab GTPase (Sec4) and Rab 
exchange factor (Sec2) but occurs independent of t-SNARE function 
(Sec9). Second, overexpression of Rab effectors in other stages of 
membrane trafficking causes membrane clustering and thus may be 
a common effect of unregulated activation of the tethering machin-
ery (Markgraf et al., 2009; Yamamoto et al., 2010). Third, the similar-
ity of the phenotype of Sro7 overexpression with that of the Sec4 
effector, Sec15 (which also clusters vesicles in a Sec4/Sec2-depen-
dent but Sec9-independent manner), suggests that Rab effectors 
may generally help to promote membrane-to-membrane interac-
tion when engaged by the GTP-bound Rab but that the specificity 
of this reaction is aided by other regulatory reactions that may keep 
it “off.”
In fact, in a side-by-side comparison, we found that both Rab ef-
fectors, Sro7 and Sec15, behave virtually identically when placed be-
hind the strong regulatable GAL promoter in wild-type cells. This sup-
ports the view that these two effectors work on parallel pathways at 
the same stage of vesicle transport to ensure proper tethering to the 
target membrane. The notion that multiple Rab effectors may play a 
synergistic role in promoting membrane tethering and fusion has re-
cently been described and proposed as a mechanism for ensuring 
the specificity and efficiency of the process (Ohya et al., 2009).
Previous studies on Sec4 have demonstrated a requirement for 
its exchange factor Sec2 in the Myo2-dependent delivery of vesicles 
to sites of polarized growth. This suggests the existence of an effec-
tor pathway for Sec4 that communicates information about the nu-
cleotide state of the Rab onto the Myo2 motor. While it is possible 
that Sro7 might have such a role, we believe this is unlikely. This 
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Roche Diagnostics, Indianapolis, IN. GDP, sorbitol, sodium azide, 
N-ethylmaleimide, β-mercaptoethanol, o-dianisidine, glucose oxi-
dase, peroxidase, Triton X-100, and NP-40 were from Sigma Aldrich, 
St. Louis, MO. Formaldehyde, glutaraldehyde, cacodylate, osmium 
oxide, uranyl acetate, and Spurr resin were obtained from EM 
Sciences, Ft. Washington, PA. Fluorescein isothiocyanate (FITC)–
conjugated donkey anti–rabbit and tetramethyl rhodamine isothio-
cyanate (TRIC)–conjugated donkey anti–mouse secondary antibod-
ies were obtained from Jackson ImmunoResearch Laboratories, West 
Grove, PA. Fluorsave Reagent was obtained from Calbiochem, San 
Diego, CA. Secondary antibodies for the Odyssey Imaging System 
are from LI-COR Biosciences, Lincoln, NE, and Molecular Probes, 
Eugene, OR. The TNT translation system is from Promega, Madison, 
WI, and the S-35 methionine and I-125 Protein A from Perkin Elmer, 
Boston, MA. His-Select HF-Nickel Affinity Gel is from Sigma. IgG 
Sepharose 6 Fast Flow, Glutathione Sepharose 4B, Protein A Sephar-
ose, and Precision Protease are from GE Healthcare, Milwaukee, WI.
Genetic techniques
The strategy for obtaining mutations in the MYO2 IQ region for in 
vitro binding mutations in the individual IQ motifs of MYO2 used for 
in vitro binding experiments was generated by two-step fusion PCR. 
In the first step, two PCR fragments were generated (using pB695 as 
a template) that shared overlapping sequences at the site of the 
mutation. Fusion PCR generated a fragment spanning animo acids 
925–990 of MYO2, which contained the point mutations at the site 
of fusion. Myo2 mutations in both IQ1 and IQ5 domains were gen-
erated by using DNA containing the myo2-iq1 mutation as a tem-
plate for the two-step fusion PCR mentioned above.
Strategy for obtaining mutations in the MYO2 IQ region for 
yeast transformation
MYO2 mutations in each individual IQ motif for yeast transformation 
were generated by two-step fusion PCR. In the first step we used 
genomic DNA to generate two PCR fragments that shared overlap-
ping sequences at the site of the mutation. These fragments were 
then combined in a fusion PCR reaction with external primers that 
would allow the formation of a BamHI-EcoRI fragment, which was 
subcloned into the BamHI-EcoRI sites of the MYO2 construct 
(pB1486). This construct was then used to generate the PCR frag-
ments containing the IQ mutations for integration into yeast.
Introducing point mutations into chromosomal MYO2
Yeast strains containing alanine substitutions in one or two IQ motifs 
of chromosomal MYO2 were generated using a two-step strategy. 
In the first step a diploid yeast strain containing a copy of myo2-
Δ6IQ marked with natR was generated (BY2250). This was obtained 
by transformation and homologous recombination of PCR frag-
ments containing myo2-Δ6IQ and the selectable marker natR into a 
wild-type diploid strain. External sequences annealed with 651 base 
pairs upstream of the chromosomal MYO2 IQ site and 48 base pairs 
downstream of the MYO2 open reading frame. Overlapping se-
quences between the PCR products directed natR 200 base pairs 
downstream of the myo2-Δ6IQ coding sequence. Diploids contain-
ing a copy of myo2-Δ6IQ showed resistance to clonNAT and the 
presence of a truncated myo2-Δ6IQ protein by Western blot analy-
sis. Diploids containing myo2-Δ6IQ were transformed with PCR 
DNA containing wild-type or mutant iq and the selectable marker 
kanR. Homologous recombination allowed the substitution of myo2-
Δ6IQ marked by natR with wild-type or iq mutant marked by kanR. 
Overlapping sequences between the transforming PCR fragments 
directed the kanR 100 base pairs downstream of the open reading 
frame of wild-type or iq mutant. External sequences directed ho-
mologous integration 651 base pairs upstream of the IQ site of 
myo2-Δ6IQ and 48 base pairs downstream of the myo2-6Δ IQ open 
reading frame. Diploids were analyzed on plates for loss of natR and 
gain of kanR resistance and by Western blot analysis for loss of the 
truncated form of myo2-Δ6IQ and gain of full-length Myo2. Diploids 
were sporulated to generate haploid wild-type and myo2-iq mutant 
strains. Genomic DNA was extracted from all strains to confirm the 
presence of the desired mutations by sequence analysis.
MYO2 or MYO2-Δ6IQ fragments for yeast transformation were 
generated by fusion PCR from pB694 and pB1176 to obtain MYO2 
and myo2-Δ6IQ containing 651 base pairs upstream and 880 base 
pairs downstream of the IQ site and genomic DNA to obtain MYO2 
containing 810 base pairs downstream of the IQ site and 200 base 
pairs downstream of the last codon. Fusion PCR generated the re-
quired fragments for yeast transformation.
Recombinant proteins
ProtA-Sro7, GST-Sec9, and GST-Myo2IQ were obtained as de-
scribed previously (Gangar et al., 2005). GST-Mlc1 was purified as 
described previously for GST fusion proteins (Rossi et al., 1997). 
Soluble Myo2-IQ (782–990) and Myo2-IQ1,5 proteins were obtained 
by precision protease cleavage of the GST fusion proteins bound to 
glutathione Sepharose beads using the manufacturer’s (GE Health-
care Milwaukee, WI) protocol.
In vitro binding assays
Radiolabeled Myo2 (782–990), Myo2 (782–925), Myo2 (871–1204), 
and Myo-IQ1,5 (782–990) with mutant IQ motifs Sro7 (1–1033), 
Sro7-Δ(3–51), and Sro7-Δ(4–18) were obtained by in vitro transcrip-
tion and translation of PCR fragments using TNT T7 Quick Master 
Mix in the presence of S-35 methionine. Binding reactions were set 
up as previously described (Gangar et al., 2005), except the radiola-
beled proteins were incubated with proASro7 bound to IgG beads 
(1 μM) or GST-Mlc1, GST-Sec9, or GST-Myo2IQ bound to glutathi-
one beads (1 μM). Control beads included ProtA bound to IgG Sep-
harose (1 μM) and GST bound to glutathione Sepharose (1 μM). PCR 
conditions for the generation of the radiolabeled proteins were al-
tered to make sure that similar amounts of wild-type and mutant 
proteins were translated. Binding assays with purified Sro7 to GST-
Sec4 were done as described previously (Grosshans et al., 2006).
Plasmid construction
1XGFPSRO7 (pB1270) was generated by introducing SRO7 (3–1033) 
obtained from genomic DNA into a plasmid containing the SRO7 
promoter region with 1XGFP (pB1261) as a BamHI-SalI fragment. 
3XGFPSRO7 (pB1564) was generated by inserting a 2XGFP frag-
ment (from pB1242) as a BglII-BamHI site into the BamHI site of 
PB1270. SRO7 in a CEN (LEU2) plasmid (pB1763) was generated by 
transformation of BY1839 with a PCR-generated fragment contain-
ing the LEU2 marker. 3XGFPSRO7 (Δ1–18) was generated by intro-
ducing SRO7 (18–1033) obtained by PCR using oligos containing 
the truncation into the BamHI-SalI site of 3XGFPSRO7 (pB1564). 
GST-Mlc1 was generated by subcloning MLC1 (1–150) obtained 
from genomic DNA into pGEX4T1 as a BamHI-SalI fragment. GST-
Myo2-IQ (782–990) and GST-Myo2-IQ1,5 were subcloned into 
pGEX6P-1 as BamHI-SalI fragments. MYO1IQ (761–932) was ob-
tained by PCR using genomic DNA as a template. SEC15 under 
regulation by the tetracycline promoter (pB1816) was generated by 
subcloning SEC15 (1–910) obtained from genomic DNA into 
pCM189 as a BamHI-NotI fragment. SRO7 (Δ4–18) under regulation 
of the tetracycline promoter (pB1947) was generated by subcloning 
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SRO7 (Δ4–18) obtained by PCR using oligos containing the deletion 
as a BamHI-NotI fragment in pCM189. SRO7 under regulation 
of the galactose-inducible promoter (pB1561) was obtained by 
subcloning SRO7 (1–1033) obtained from genomic DNA into 
pNB527 as a BamHI-HindIII fragment. SEC15 under regulation of 
the galactose-inducible promoter was obtained by subcloning 
SEC15 (1–910) obtained from genomic DNA into pNB527 as a 
BamHI-HindIII fragment.
Bgl2 and invertase assays
Wild-type and mutant myo2iq-1,5 and sec4-P48 mutants were 
grown overnight to midlog phase in YPD at the permissive tempera-
ture of 32°C. Samples for the Bgl2 and invertase assays were taken 
before and after an 8-h shift to the restrictive temperature of 25°C 
and processed as described previously (Adamo et al., 1999)
Growth conditions for fluorescence and electron microscopy
The myo2iq-1,5 mutant cells expressing Sro7 from a tetracycline-
regulatable promoter were grown to midlog in selective media at 
the permissive temperature of 32°C in the presence of doxycycline 
(1 mg/l) and then shifted to the restrictive temperature of 25°C in 
selective media in the absence of doxycycline for 8 h before being 
processed for microscopy.
Wild-type strains expressing Sro7 or Sec15 from the galactose-
inducible promoter were grown in raffinose (3%) to midlog and then 
induced for 10 h with galactose (1%) before fixing and processing 
for microscopy. All samples were treated as previously described 
(Adamo et al., 1999).
Fluorescence and immunofluorescence microscopy
All strains analyzed were grown overnight to midlog in selective me-
dia, shifted into fresh media for one generation of growth or shifted 
to restrictive conditions, and then fixed and processed as described 
previously (Brennwald and Novick, 1993; Roumanie et al., 2005). 
GFP and RFP fluorescence was detected using MetaMorph soft-
ware. Immunofluorescence was conducted using monoclonal mouse 
anti-Sec4 (1:100 dilution) and affinity-purified polyclonal rabbit anti-
Sro7 and anti-Sec15 antibodies (1:100 dilution). TRIC-conjugated 
donkey anti–mouse secondary antibodies were used to detect Sec4 
(1:100 dilution), and FITC-conjugated donkey anti–rabbit (1:100 di-
lution) secondary antibodies were used to detect Sro7 and Sec15 
(1:100 dilution).
Immunoprecipitations
Immunoprecipitations from detergent lysates with anti-Sro7 and 
anti-Myo2 antibodies were performed as described previously 
(Gangar et al., 2005).
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